妊娠期糖尿病通过氧化甲硫酸盐水平升高增加了早产膜破裂的风险
Ying Li1, Rong Lin1, Tianshu Zhang1
1Department of Obstetrics and Gynecology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China.
Frontiers in endocrinology
|September 18, 2025
概括
妊娠期糖尿病 (GDM) 通过改变胎儿膜完整性增加了膜过早破裂 (PROM) 的风险. 在GDM患者中,氧化甲基二烯硫酸的升高水平可能作为PROM风险的生物标志物.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 孕期糖尿病 (GDM) 是一种常见的妊娠并发症.
- GDM与不良妊娠结果的风险增加有关,包括膜的过早破裂 (PROM).
- 连接GDM与PROM的特定代谢途径尚未完全理解.
研究的目的:
- 研究GDM和PROM之间的关联背后的代谢机制.
- 确定GDM妇女中PROM风险的潜在代谢生物标志物.
- 探索改善GDM患者怀孕结果的治疗目标.
主要方法:
- 分析了来自GDM母亲和儿童研究 (GMCS) 的354名母亲的队列.
- 使用回归模型来评估GDM和PROM之间的关系.
- 第三个三个月的血清样本使用超高性能液态染色学和高分辨率质谱学分析了代谢物概况.
主要成果:
- 患有PROM的女性患有GDM的患病率显著更高 (32.3%对比15.7%).
- 在PROM组中观察到高的禁食葡萄糖水平.
- 孕期糖尿病被证实是PROM的独立风险因素 (调整的OR:2.538).
- 在GDM-PROM病例中发现了显著升高的氧甲硫酸水平.
结论:
- 孕期糖尿病通过影响胎儿膜完整性的代谢失调增加了PROM风险.
- 氧化甲基二烯硫酸盐的升高水平可能成为GDM中PROM风险的潜在生物标志物.
- 早期代谢查和血糖控制对于管理GDM和降低PROM风险至关重要.
更多相关视频
相关概念视频
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Dipeptidyl Peptidase 4 Inhibitors
596
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
596
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones
587
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
587


